{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:33:16Z","timestamp":1791729196071,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T04:47:52Z","timestamp":1389415672000},"page":"556-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-3254","authenticated-orcid":false,"given":"Joshua G.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur-Quan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4808-3805","authenticated-orcid":false,"given":"B.J.","family":"Rimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Cass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0005","first-page":"11","volume":"63","author":"Siegel","year":"2013","journal-title":"Cancer Stat"},{"issue":"19","key":"10.1016\/j.ygyno.2014.01.003_bb0010","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1002\/cncr.28183","article-title":"A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value","volume":"119","author":"Lu","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2014.01.003_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2014.01.003_bb0020","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.003_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.01.003_bb0030","first-page":"CD008765","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"2","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ygyno.2014.01.003_bb0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1634\/theoncologist.2011-0373","article-title":"The role of secondary cytoreductive surgery in patients with recurrent epithelial ovarian, tubal, and peritoneal cancers: a comparative effectiveness analysis","volume":"17","author":"Chuang","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.003_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"24","key":"10.1016\/j.ygyno.2014.01.003_bb0050","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","article-title":"Platelets increase the proliferation of ovarian cancer cells","volume":"120","author":"Cho","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ygyno.2014.01.003_bb0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","article-title":"Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis","volume":"26","author":"Holmes","year":"2009","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"10.1016\/j.ygyno.2014.01.003_bb0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ygyno.2014.01.003_bb0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jso.23163","article-title":"Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer","volume":"106","author":"Ishizuka","year":"2012","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00268-011-1329-7","article-title":"Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer","volume":"36","author":"Sasaki","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.ygyno.2014.01.003_bb0075","doi-asserted-by":"crossref","first-page":"289563","DOI":"10.1155\/2013\/289563","article-title":"Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer","volume":"2013","author":"Stravodimou","year":"2013","journal-title":"Int J Breast Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2014.01.003_bb0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejso.2012.04.009","article-title":"Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer","volume":"38","author":"Hwang","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.01.003_bb0085","first-page":"1725","article-title":"Thrombocytosis has a negative prognostic value in lung cancer","volume":"33","author":"Mar\u00e1z","year":"2013","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2003.09.002","article-title":"The prognostic significance of thrombocytosis in epithelial ovarian carcinoma","volume":"92","author":"Li","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0377-4929.59184","article-title":"Significance of preoperative thrombocytosis in epithelial ovarian cancer","volume":"53","author":"Crasta","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.003_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2013.05.038","article-title":"Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer","volume":"130","author":"Allensworth","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.01.003_bb0105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.2012.01991.x","article-title":"Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance","volume":"167","author":"Radziwon Balicka","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.003_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00404-008-0673-9","article-title":"The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors","volume":"279","author":"Gungor","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.ygyno.2014.01.003_bb0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1078-0432.CCR-12-2243","article-title":"New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential","volume":"19","author":"Banerjee","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.ygyno.2014.01.003_bb0120","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2012-09-457325","article-title":"Platelets signal and tumors take off","volume":"120","author":"Rao","year":"2012","journal-title":"Blood"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T07:23:20Z","timestamp":1538897000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814000146"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}